With this study, we investigated the IL-12/STAT4, IL-23/STAT3, and IL-6/STAT3 pathways in patients with relapsing-remitting MS (RRMS) and the potential impact of genetic background on activation of these pathways. Here, STAT3 is linked to relapsing-remitting multiple sclerosis.